Sahajanand Medical Technologies Limited IPO Allotment Status

Sahajanand Medical Technologies IPO is a book build issue of ₹475.48 crore. 

Sahajanand Medical Technologies Limited is a book-built BSE and NSE IPO with a price band of ₹327–₹344 per equity share. The bidding window opened on October 15, 2026, and closes today, October 19, 2026. 

The basis of allotment is expected to be finalised on October 21, 2026. Refunds for unsuccessful applicants and credit of shares to successful applicants’ demat accounts are expected on October 22, 2026, while the shares are scheduled to list on BSE and NSE on October 23, 2026. 

The IPO has a market lot of 43 shares. At the upper price band, one lot costs ₹14,792. The minimum retail application is one lot, or 43 shares, requiring ₹14,792. 

Motilal Oswal Investment Advisors Ltd., Avendus Capital Pvt. Ltd., HSBC Securities & Capital Markets (India) Pvt. Ltd. and Nuvama Wealth Management Ltd. are the book running lead managers. 

Investors can check Sahajanand Medical Technologies IPO allotment status after the basis of allotment is finalised through MUFG Intime India Private Limited, the registrar to the issue, or through the NSE/BSE IPO-status facilities. 

How to Check Sahajanand Medical Technologies IPO Allotment Status Online on NSE? 

• Visit the NSE IPO bid-verification/application-status page.
• Select “Equity” under Issue Type.
• Choose “Sahajanand Medical Technologies Limited” from the Issue Name dropdown after the allotment data is published.
• Enter your PAN or Application Number.
• Complete the captcha verification, where applicable.
• Click on Submit or Search to view your application and allotment status. 

How to Check Sahajanand Medical Technologies IPO Allotment Status Online on BSE? 

• Visit the BSE IPO allotment-status page.
• Select “Equity” under Issue Type.
• Choose “Sahajanand Medical Technologies Limited” from the Issue Name dropdown after the allotment data is published.
• Enter your Application Number or PAN.
• Tick the “I’m not a robot” captcha.
• Click on Search to view your application and allotment status. 

How to Check Sahajanand Medical Technologies IPO Allotment Status on the Registrar’s Website? 

• Visit the official MUFG Intime India IPO allotment-status website.
• Select “Sahajanand Medical Technologies Limited” from the IPO-name dropdown once the registrar uploads the basis-of-allotment information.
• Choose PAN, Application Number or DP ID/Client ID as the search method.
• Enter the required details.
• Complete the captcha verification.
• Click on Submit or Search to view your allotment result. 

Sahajanand Medical Technologies IPO Details 

Sahajanand Medical Technologies IPO is a book build issue of ₹475.48 crore. 

Sahajanand Medical Technologies’ IPO is priced in the range of ₹327–₹344 per equity share. The face value of each equity share is ₹1. The company’s issue is proposed to list on BSE and NSE. 

The IPO opened on October 15, 2026, and closes on October 19, 2026. The basis of allotment is expected on October 21, 2026, refunds and demat credits are expected on October 22, 2026, and the shares are scheduled to list on BSE and NSE on October 23, 2026. 

The market lot comprises 43 shares, requiring ₹14,792 at the upper price band. The minimum retail application is one lot, or 43 shares, requiring ₹14,792. Applications can be made in permitted multiples of 43 shares thereafter. 

Allocation Quota for Sahajanand Medical Technologies IPO 

Note: Category-wise shares offered and subscription figures vary slightly across sources and updates; the final basis of allotment published by MUFG Intime India will be definitive.  

Read More: How JioBrain Is Helping Jio Build an AI-Native Digital Business Ahead of IPO? 

Sahajanand Medical Technologies IPO – Overall Subscription Status 

As of the latest available update on October 19, 2026, at 5:54:57 PM (Day 3), the Sahajanand Medical Technologies IPO was subscribed 14.21 times overall. The non-institutional investor (NII) category was subscribed 14.64 times, the QIB (Ex Anchor) category 34.70 times, and the retail (Individual Investors) category 3.04 times. These figures may change slightly following exchange reconciliation after the issue closes. 

Sahajanand Medical Technologies IPO Subscription Details 

Note: Shares Offered and Total Amount are calculated at the upper price band. The Total row excludes the Anchor portion. 

Sahajanand Medical Technologies Business Overview 

Incorporated in October 2001, Sahajanand Medical Technologies Limited is a medical technology company engaged in the development, manufacturing and marketing of technologically advanced medical devices, primarily focused on vascular intervention and structural heart intervention. Its product portfolio includes coronary stents, coronary balloons, transcatheter aortic valve implantation (TAVI) devices, occluders, renal stents and peripheral drug-coated balloons (DCBs). The Company focuses on research and development, precision manufacturing and clinically supported product innovation. Its flagship brands include Supraflex Cruz, Cocoon and Hydra, serving different areas of interventional cardiology. 

The Company operates three manufacturing facilities, two in India and one in Thailand, supported by two R&D centres in India and Thailand. As of June 30, 2026, it had 119 patents granted globally, 78 patent applications in the pipeline and five design registrations in India. Its products were marketed in 77 countries in Fiscal 2026, through direct, hybrid and distributor-led models, with established market presence in India, Europe and other international markets. 

The Company reported revenue from operations of ₹12,105.04 million in Fiscal 2026, compared with ₹10,248.79 million in Fiscal 2025 and ₹9,016.04 million in Fiscal 2024. 

As of June 30, 2026, it had 1,605 full-time employees, 31 consultants and 707 contract-based employees. 

Sahajanand Medical Technologies IPO allotment status is expected to be available on October 21, 2026, after approval of the basis of allotment. Investors should check MUFG Intime India or NSE/BSE using their PAN, application number or DP ID/Client ID. 

Know more about IPO allotment status and check your application details online for the latest updates on share allocation. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.   

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.